1. Home
  2. IPSC
  3. IPSC News

Latest Century Therapeutics Inc. (IPSC) News on November 28, 2025

Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
IPSC

GlobeNewswire

3 days ago

Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

IPSC

MT Newswires

11 days ago

Century Therapeutics Shares Fall After Leerink Partners Downgrade

Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
IPSC

GlobeNewswire

15 days ago

Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
IPSC

GlobeNewswire

15 days ago

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
IPSC

GlobeNewswire

a month ago

Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference

We Think Century Therapeutics (NASDAQ:IPSC) Needs To Drive Business Growth Carefully
IPSC

Simply Wall St.

2 months ago

We Think Century Therapeutics (NASDAQ:IPSC) Needs To Drive Business Growth Carefully

Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum
IPSC

Zacks

5 months ago

Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum

Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
IPSC

Zacks

6 months ago

Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
IPSC

GlobeNewswire

6 months ago

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress

IPSC

MT Newswires

6 months ago

Chardan Trims Price Target on Century Therapeutics to $6 From $7, Maintains Buy Rating

Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates
IPSC

Zacks

6 months ago

Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
IPSC

GlobeNewswire

6 months ago

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics, Inc. (IPSC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
IPSC

Zacks

7 months ago

Century Therapeutics, Inc. (IPSC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
IPSC

GlobeNewswire

7 months ago

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
IPSC

GlobeNewswire

7 months ago

Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025

Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock?
IPSC

Zacks

8 months ago

Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock?

IPSC

MT Newswires

8 months ago

Chardan Cuts Price Target on Century Therapeutics to $7 From $11, Keeps Buy Rating

Century Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
IPSC

Simply Wall St.

8 months ago

Century Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

IPSC

MT Newswires

8 months ago

Leerink Partners Adjusts Price Target on Century Therapeutics to $8 From $13, Keeps Outperform Rating

Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates
IPSC

Zacks

8 months ago

Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
IPSC

GlobeNewswire

8 months ago

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders
IPSC

GlobeNewswire

10 months ago

Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders

IPSC

MT Newswires

a year ago

Piper Sandler Adjusts Price Target on Century Therapeutics to $4 From $12, Keeps Overweight Rating

Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
IPSC

GlobeNewswire

a year ago

Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

What Makes Century Therapeutics (IPSC) a New Buy Stock
IPSC

Zacks

a year ago

What Makes Century Therapeutics (IPSC) a New Buy Stock

Century Therapeutics Third Quarter 2024 Earnings: Beats Expectations
IPSC

Simply Wall St.

a year ago

Century Therapeutics Third Quarter 2024 Earnings: Beats Expectations

IPSC

MT Newswires

a year ago

Century Therapeutics Shares Rise After Q3 Beats Estimates

Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates
IPSC

Zacks

a year ago

Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
IPSC

GlobeNewswire

a year ago

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
IPSC

GlobeNewswire

a year ago

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting

Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
IPSC

GlobeNewswire

a year ago

Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference

We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate
IPSC

Simply Wall St.

a year ago

We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate

electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar?
IPSC

Zacks

a year ago

electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar?

IPSC

MT Newswires

a year ago

Century Therapeutics Appoints Chief Scientific Officer, Finance Chief

Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
IPSC

GlobeNewswire

a year ago

Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer

Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates
IPSC

Zacks

a year ago

Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates

Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
IPSC

GlobeNewswire

a year ago

Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

After losing 17% in the past year, Century Therapeutics, Inc. (NASDAQ:IPSC) institutional owners must be relieved by the recent gain
IPSC

Simply Wall St.

a year ago

After losing 17% in the past year, Century Therapeutics, Inc. (NASDAQ:IPSC) institutional owners must be relieved by the recent gain

Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade
IPSC

Zacks

a year ago

Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade

IPSC

MT Newswires

a year ago

Century Therapeutics Proposes Secondary Offering of 7.87 Million Shares

IPSC

MT Newswires

a year ago

Piper Sandler Adjusts Price Target on Century Therapeutics to $12 From $9, Maintains Overweight Rating

Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
IPSC

GlobeNewswire

a year ago

Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting

IPSC

GuruFocus.com

2 years ago

Century Therapeutics Inc (IPSC) Q1 2024 Earnings: Aligns with EPS Projections Amid Strategic ...

Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
IPSC

GlobeNewswire

2 years ago

Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting

Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates
IPSC

Zacks

2 years ago

Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates

Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
IPSC

GlobeNewswire

2 years ago

Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
IPSC

GlobeNewswire

2 years ago

Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

Century buys a startup, raises funding in cell therapy expansion
IPSC

BioPharma Dive

2 years ago

Century buys a startup, raises funding in cell therapy expansion

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
IPSC

GlobeNewswire

2 years ago

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
IPSC

GlobeNewswire

2 years ago

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Century Therapeutics (NASDAQ:IPSC) Will Have To Spend Its Cash Wisely
IPSC

Simply Wall St.

2 years ago

Century Therapeutics (NASDAQ:IPSC) Will Have To Spend Its Cash Wisely

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
IPSC

GlobeNewswire

2 years ago

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors

Amneal (AMRX) Stock Jumps 7.3%: Will It Continue to Soar?
IPSC

Zacks

2 years ago

Amneal (AMRX) Stock Jumps 7.3%: Will It Continue to Soar?

Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
IPSC

GlobeNewswire

2 years ago

Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
IPSC

GlobeNewswire

2 years ago

Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

Century Therapeutics Inc (IPSC) COO Adrienne Farid Sells 53,515 Shares
IPSC

GuruFocus.com

2 years ago

Century Therapeutics Inc (IPSC) COO Adrienne Farid Sells 53,515 Shares

How Much Upside is Left in Century Therapeutics, Inc. (IPSC)? Wall Street Analysts Think 193.4%
IPSC

Zacks

2 years ago

How Much Upside is Left in Century Therapeutics, Inc. (IPSC)? Wall Street Analysts Think 193.4%

Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
IPSC

GlobeNewswire

2 years ago

Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
IPSC

GlobeNewswire

2 years ago

Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Can Alerus (ALRS) Run Higher on Rising Earnings Estimates?
IPSC

Zacks

2 years ago

Can Alerus (ALRS) Run Higher on Rising Earnings Estimates?

AMSC Announces Proposed Public Offering of Common Stock
IPSC

GlobeNewswire

2 years ago

AMSC Announces Proposed Public Offering of Common Stock

Nexxen Appoints Gretchen Johnson as Chief People Officer
IPSC

GlobeNewswire

2 years ago

Nexxen Appoints Gretchen Johnson as Chief People Officer

Bridge Investment Group Announces Date of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
IPSC

Business Wire

2 years ago

Bridge Investment Group Announces Date of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Bread Financial (BFH) Q4 Earnings Beat, Revenues Fall Y/Y
IPSC

Zacks

2 years ago

Bread Financial (BFH) Q4 Earnings Beat, Revenues Fall Y/Y

First Business Financial Services (FBIZ) Q4 Earnings Top Estimates
IPSC

Zacks

2 years ago

First Business Financial Services (FBIZ) Q4 Earnings Top Estimates

The Manitowoc Company, Inc. (MTW) Stock Declines While Market Improves: Some Information for Investors
IPSC

Zacks

2 years ago

The Manitowoc Company, Inc. (MTW) Stock Declines While Market Improves: Some Information for Investors

Vehicle Retailer Stocks Q3 Teardown: CarMax (NYSE:KMX) Vs The Rest
IPSC

StockStory

2 years ago

Vehicle Retailer Stocks Q3 Teardown: CarMax (NYSE:KMX) Vs The Rest

IPSC

Reuters

2 years ago

UPDATE 3-SEC probes B. Riley deals with client tied to failed hedge fund - Bloomberg News

B. Riley Financial Issues Statement
IPSC

PR Newswire

2 years ago

B. Riley Financial Issues Statement

Companies Like Telos (NASDAQ:TLS) Can Afford To Invest In Growth
IPSC

Simply Wall St.

2 years ago

Companies Like Telos (NASDAQ:TLS) Can Afford To Invest In Growth

Talos Energy Announces Commencement of Underwritten Public Offering of Common Stock
IPSC

PR Newswire

2 years ago

Talos Energy Announces Commencement of Underwritten Public Offering of Common Stock

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger
IPSC

Simply Wall St.

2 years ago

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger

The past three years for Nexxen International (LON:NEXN) investors has not been profitable
IPSC

Simply Wall St.

2 years ago

The past three years for Nexxen International (LON:NEXN) investors has not been profitable

Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
IPSC

GlobeNewswire

2 years ago

Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole

Havertys Announces Participation in Water Tower Research Furniture/Furnishings Virtual Conference
IPSC

ACCESSWIRE

2 years ago

Havertys Announces Participation in Water Tower Research Furniture/Furnishings Virtual Conference

Nexxen to Present at the Needham Growth Conference
IPSC

GlobeNewswire

2 years ago

Nexxen to Present at the Needham Growth Conference

Liquidity Services Acquires Sierra Auction, a Leading Auctioneer of Vehicles, Equipment, and Surplus Assets for Government and Commercial Organizations
IPSC

GlobeNewswire

2 years ago

Liquidity Services Acquires Sierra Auction, a Leading Auctioneer of Vehicles, Equipment, and Surplus Assets for Government and Commercial Organizations

IPSC

Oilprice.com

2 years ago

2023 Was a Bad Year for Commodities

Beyond Meat: How the plant-based CEO leads an uphill battle
IPSC

Yahoo Finance Video

2 years ago

Beyond Meat: How the plant-based CEO leads an uphill battle

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools
IPSC

PR Newswire

2 years ago

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools

IPSC

GlobeNewswire

2 years ago

Diana Shipping Inc. Announces Time Charter Contract for m/v DSI Pollux With Cargill Ocean Transportation

Trinity Capital Inc. Announces Phoenix Headquarters Expansion, Highlighting Company's Continued Growth and Success
IPSC

PR Newswire

2 years ago

Trinity Capital Inc. Announces Phoenix Headquarters Expansion, Highlighting Company's Continued Growth and Success

Here’s Why Vista Outdoor (VSTO) Rose in Q3
IPSC

Insider Monkey

2 years ago

Here’s Why Vista Outdoor (VSTO) Rose in Q3

A Piece Of The Puzzle Missing From agilon health, inc.'s (NYSE:AGL) Share Price
IPSC

Simply Wall St.

2 years ago

A Piece Of The Puzzle Missing From agilon health, inc.'s (NYSE:AGL) Share Price

Are Investors Undervaluing Dana Incorporated (NYSE:DAN) By 31%?
IPSC

Simply Wall St.

2 years ago

Are Investors Undervaluing Dana Incorporated (NYSE:DAN) By 31%?

Unisys Named a Leader in 2023 ISG Provider Lens™️ Future of Work (Workplace) -- Services and Solutions Report (Global)
IPSC

PR Newswire

2 years ago

Unisys Named a Leader in 2023 ISG Provider Lens™️ Future of Work (Workplace) -- Services and Solutions Report (Global)

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
IPSC

GlobeNewswire

2 years ago

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

Implied Volatility Surging for W&T Offshore (WTI) Stock Options
IPSC

Zacks

2 years ago

Implied Volatility Surging for W&T Offshore (WTI) Stock Options

Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study
IPSC

Zacks

2 years ago

Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study

The Hackett Group Launches Ai XPLR: A Pioneering Gen AI Readiness and Opportunity Assessment
IPSC

Business Wire

2 years ago

The Hackett Group Launches Ai XPLR: A Pioneering Gen AI Readiness and Opportunity Assessment

Century Therapeutics, Inc.'s (NASDAQ:IPSC) largest shareholders are public companies who were rewarded as market cap surged US$47m last week
IPSC

Simply Wall St.

2 years ago

Century Therapeutics, Inc.'s (NASDAQ:IPSC) largest shareholders are public companies who were rewarded as market cap surged US$47m last week

D-Market Elektronik Hizmetler ve Ticaret A.S. (NASDAQ:HEPS) Q3 2023 Earnings Call Transcript
IPSC

Insider Monkey

2 years ago

D-Market Elektronik Hizmetler ve Ticaret A.S. (NASDAQ:HEPS) Q3 2023 Earnings Call Transcript

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus
IPSC

GlobeNewswire

2 years ago

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus

Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
IPSC

GlobeNewswire

2 years ago

Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential
IPSC

InvestorPlace

2 years ago

Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential

Mercer International (NASDAQ:MERC) Is Paying Out A Dividend Of $0.075
IPSC

Simply Wall St.

2 years ago

Mercer International (NASDAQ:MERC) Is Paying Out A Dividend Of $0.075

National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12
IPSC

Simply Wall St.

2 years ago

National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12

Wall Street Analysts Predict an 87.26% Upside in Anterix (ATEX): Here's What You Should Know
IPSC

Zacks

2 years ago

Wall Street Analysts Predict an 87.26% Upside in Anterix (ATEX): Here's What You Should Know

Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
IPSC

GlobeNewswire

2 years ago

Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference

While insiders own 33% of Red River Bancshares, Inc. (NASDAQ:RRBI), retail investors are its largest shareholders with 46% ownership
IPSC

Simply Wall St.

2 years ago

While insiders own 33% of Red River Bancshares, Inc. (NASDAQ:RRBI), retail investors are its largest shareholders with 46% ownership

Share on Social Networks: